Hudson Bay Capital Management LP
Position in NBIX — Neurocrine Biosciences Inc
CIK 1393825
STAMFORD, CT
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,910,200
-$30,239,078 QoQ
Shares Held
130,000
-67.2% QoQ
Ownership
0.128%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#105
of 768 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Hudson Bay Capital Management LP holds $72,604,865 across 10 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (30.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BHC |
Bausch Health Companies Inc.
|
5,000,000 | $24,650,000 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
130,000 | $21,910,200 | |
| 3 | GLAS |
Glass House Brands Inc.
|
750,000 | $9,750,000 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
275,000 | $4,408,250 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
400,000 | $4,000,000 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
5,000 | $2,709,150 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
70,009 | $2,427,211 | |
| 8 | AQST |
Aquestive Therapeutics, Inc.
|
234,000 | $973,440 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,910,200 | 130,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $52,149,278 | 395,850 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $43,258,150 | 305,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,686,793 | 40,510 | Shares | Sole | 2025-12-15 | |
| 2025-06-30 | $9,752,664 | 77,593 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $16,632,028 | 150,380 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,141,683 | 30,342 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,608,800 | 40,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,195,150 | 45,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,137,600 | 30,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,576,200 | 57,500 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,625,000 | 50,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,308,250 | 77,500 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,036,600 | 30,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,294,729 | 10,840 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $11,152,050 | 105,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $16,571,600 | 170,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $14,531,250 | 155,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $11,497,950 | 135,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,662,153 | 79,889 | Shares | Sole | 2021-12-29 | |
| 2021-06-30 | $6,812,400 | 70,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,321,250 | 65,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $6,709,500 | 70,000 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,884,800 | 30,000 | Shares | Sole | 2020-11-12 | |
| 2020-03-31 | $865,500 | 10,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||